Mobile Cardiac Telemetry Devices Market : Current Scenario and Forecast (2019-2025): Emphasis on Technology (Lead-Based, Patch Based), End-Users (Hospitals, Ambulatory Surgical Centres, Home Setting) and Region/Country
- UNI4065894
- 231 Pages
- November 2019
- Healthcare
In recent years the prevalence of chronic diseases has increased due to the rise in life expectancy and changes in lifestyle, and thus people suffering from these pathologies often need continuous monitoring of their vital signs. The mobile health field can provide new access opportunities for treatment and medical services, constituting a valuable support instrument for both patients and doctors. Mobile cardiac telemetry (MCT) is a relatively new technology, first approved in 2002 by the US Food and Drug Administration (FDA), which provides continuous real-time outpatient electrocardiographic monitoring for extended periods of time. MCT allows the detection of both symptomatic and asymptomatic arrhythmias and has been proven to provide superior diagnostic capability for patients with palpitations, syncope, and pre-syncope. It also allows accurate monitoring of a patient’s rhythm during outpatient drug titration, as well as detection of both symptomatic and asymptomatic atrial fibrillation after cardiac ablation.
“Lead based MCT devices held the largest market share 60.2% in 2018”
Based on technology type, the global Mobile Cardiac Telemetry Devices market is bifurcated into Lead based and Patch based devices. Lead based devices dominated the market in 2018, with the maximum share in terms of revenue and are expected to maintain its dominance throughout the forecast period, owing to its increased application in high-end vehicles. Patch based devices, on the other hand, is expected to register the fastest growth during the forecast period.
“Hospitals are the major adopter of Mobile Cardiac Telemetry Devices technology”
Hospitals, Ambulatory Surgical Centers and Home Settings are the major end-users considered in the global Mobile Cardiac Telemetry Devices market study. Hospitals are the major end-users of mobile telemetry device technology; the segment generated a revenue of US$ 350.5 million in 2018. The hospital's end-user segment is expected to grow at a CAGR of 11.67% during the forecast period. However, the home setting is expected to witness highest CAGR during the 2019-2025 period.
“Europe dominated the global Mobile Cardiac Telemetry Devices market in 2018”
Also, for better understanding of the overall adoption rate of mobile cardiac telemetry devices in different developed and developing markets, detailed analysis has been conducted for different regions/countries including North America (US, Canada), Europe (UK, Germany, France, Spain, Italy), Asia-Pacific (China, India, Japan, Australia), and the Rest of the World (Middle East and Latin America). Based on the estimation, Europe dominated the Mobile Cardiac Telemetry devices market, accounting for a revenue share of 31.9% in 2018. The rising incidence of cardiovascular diseases in Europe is influencing the healthcare service providers to implement advanced telehealth services. Hence, the increasing usage of telecardiology is expected to drive the market.
Competitive Landscape-Top 10 Market Players
Asahi Kasei Corp., BioTelemetry Inc., Biotricity, Comarch, Hill-Rom Holdings Inc, Infobionic, Koninklijke Philips N.V., Medicalgorithmics, Medicomp and Preventice are some of the prominent players operating in the global Mobile Cardiac Telemetry Devices industry. These players are adopting several growth strategies including acquisition, product launches, partnership and business expansion to increase their market presence and benefit as first mover advantages. The industry has also witnessed the emergence of several start-ups in the respective domain, majorly in the European region.
Reasons to buy (The research report presents):
• Current and future market size from 2018 to 2025 in terms of value (US$)
• Combined analysis of deep dive secondary research and input from primary research through Key Opinion Leaders of the industry
• Country level details of the overall adoption of MCT devices in major healthcare facilities and current and future health status of the country
• A quick review of overall industry performance at a glance
• In-depth analysis of key industry players
• A detailed analysis of regulatory framework, drivers, restraints, key trends and opportunities prevailing in the industry
• Examination of industry attractiveness with the help of Porter’s Five Forces analysis and start ups
• The study comprehensively covers the market across different segments and sub-segments of the technology
• Region/country Covered: North America (US, Canada), Europe (UK, Germany, France, Spain, Italy), Asia-Pacific (China, India, Japan, Australia), and the Rest of the World
Customization Options:
UMI understands that you may have your own business need, hence we also provide fully customized solutions to clients. The Global Mobile Cardiac Telemetry Devices Market can be customized to country level or any other market segment.
1.1 Market Definition 17
1.2 Objective of the Study 17
1.3 Limitation 17
1.4 Stakeholders 18
1.5 Currency used in the Report 18
1.6 Scope of the Global Mobile Cardiac Telemetry Devices Market Study 18
2. RESEARCH METHODOLOGY OR ASSUMPTION 19
2.1 Research Methodology for Global Mobile Cardiac Telemetry Devices Market Study 19
2.1.1 Main objective of the Global Mobile Cardiac Telemetry Devices Market Study 20
3. INDUSTRY PERFORMANCE 21
4. EXECUTIVE SUMMARY 22
4.1 Key Facts on Cardiovascular diseases (CVDs), Global 23
5. MARKET OVERVIEW 25
5.1 Market Introduction 25
5.2 Market Trend & Drivers 29
5.2.1 Increasing prevalence of Cardiovascular Diseases 29
5.2.1.1 Market trends reshaping the CVD market 31
5.2.1.1.1 Increasing demand for value 31
5.2.1.1.2 The rising uptake of Innovative Treatment Technologies 32
5.2.1.1.3 Growing Digital Solutions Adoption 33
5.2.1.1.4 Changing MedTech competitive landscape 33
5.2.1.1.5 Evolving provider and care delivery shifts 34
5.2.2 Rising Geriatric Population 34
5.2.3 Next-Generation Devices for Miniaturization, Faster Processing and Connectivity 36
5.2.4 Increasing Medical Tourism in Emerging Nations 36
5.3 Market Challenges 38
5.3.1 Clinical Effectiveness 38
5.3.2 Need for validation, cost-effectiveness 40
5.3.3 Data Security 41
5.4 Market Trends 43
5.4.1 Interoperability and Wireless Technology to Enhance Real-Time, Remote Monitoring 43
5.4.2 Transition of Care Delivery from Hospital to Home 45
6. REIMBURSEMENT POLICY 46
6.1 General Overview 46
6.1.1 Holter Monitoring reimbursement 46
6.1.2 Mobile Cardiac Telemetry Reimbursement 46
6.1.3 Cardiac Event Monitoring Reimbursement 47
6.2 Medicare National Coverage 47
6.3 2017 ISHNE-HRS expert consensus statement on ambulatory ECG and external cardiac monitoring/ telemetry 47
6.3.1 Reimbursement 53
6.3.2 Reimbursement in Europe 55
7. LEGAL & REGULATORY FRAMEWORK 59
7.1 General Overview 59
7.2 Criteria/Guidelines 60
7.3 Criteria/Guidelines 60
7.4 Limitations 61
7.5 Administrative Guidelines 61
7.6 Observational Study 63
7.7 Practice Guidelines and Position Statements 63
7.8 Telemetry Devices to Monitor Cardiac Patients: Safety and Guidelines in Canada 64
7.9 The legal framework in regulating remote (cardiac) monitoring in France 64
7.10 The legal framework in regulating remote (cardiac) monitoring in Italy 64
8. DEMAND AND SUPPLY SIDE ANALYSIS 66
8.1 Demand Side Analysis 66
8.2 Supply Side Analysis 68
8.2.1 Top Product Launches under Mobile Cardiac Telemetry Devices 70
8.2.2 Top Partnerships under Mobile Cardiac Telemetry Devices 72
8.2.3 Top Mergers & Acquisitions under Mobile Cardiac Telemetry Devices 73
8.2.4 Top Business Expansion & Investment under Mobile Cardiac Telemetry Devices 75
9. VALUE CHAIN ANALYSIS 77
9.1 Value Chain Analysis 77
10. MARKET INSIGHTS BY TECHNOLOGY 78
10.1 General Overview 78
10.1.1 Lead-Based MCT Device 80
10.1.1.1 Case Study 1- Superiority of MCT Devices 83
10.1.2 Patch Based MCT Device 83
10.1.2.1 Case study 2- Superiority of MCT Devices 85
11. MOBILE CARDIAC TELEMETRY DEVICE MARKET INSIGHTS, BY END-USERS 86
11.1 General Overview 86
11.1.1 Hospitals 90
11.1.1.1 Case Study 3- Superiority of MCT Devices 92
11.1.2 Ambulatory Surgical Centres 92
11.1.2.1 Case study 4- Superiority of MCT Devices 94
11.1.3 Home Setting 94
11.1.3.1 Case Study 5-Cost-Effectiveness of Mobile Cardiac Telemetry 97
12. MARKET INSIGHTS BY REGION 98
12.1 General Overview 98
12.2 North America Mobile Cardiac Telemetry Devices Market (2019-2025) 99
12.2.1 North America MCT Devices Market by Technology 100
12.2.2 North America Mobile Cardiac Telemetry Devices Market by End-User 101
12.2.3 North America Mobile Cardiac Telemetry Devices Market by Country 101
12.2.3.1 United States Mobile Cardiac Telemetry Devices Market (2019-2025) 102
12.2.3.1.1 Facts on Heart Disease in the US 104
12.2.3.1.2 Facts on Coronary Heart Disease (CHD) in the US 104
12.2.3.1.3 Facts on Stoke in the US 105
12.2.3.1.4 US Mobile Cardiac Telemetry Devices Market by Technology 106
12.2.3.1.5 US Mobile Cardiac Telemetry Devices Market by End-User 106
12.2.3.2 Canada Mobile Cardiac Telemetry Devices Market (2018-2025) 107
12.2.3.2.1 Facts on heart disease in Canada 110
12.2.3.2.2 Canada Mobile Cardiac Telemetry Devices Market by Technology 110
12.2.3.2.3 Canada Mobile Cardiac Telemetry Devices Market by End-User 111
12.2.3.3 Rest of North America Mobile Cardiac Telemetry Devices Market (2018-2025) 111
12.2.3.3.1 Rest of NA Mobile Cardiac Telemetry Devices Market by Technology 112
12.2.3.3.2 Rest of NA Mobile Cardiac Telemetry Devices Market by End-User 112
12.3 Europe Mobile Cardiac Telemetry Devices Market (2018-2025) 113
12.3.1 Facts on Cardiovascular Disease in Europe 114
12.3.2 Europe Mobile Cardiac Telemetry Devices Market by Technology 115
12.3.3 Europe Mobile Cardiac Telemetry Devices Market by End-User 115
12.3.4 Europe Mobile Cardiac Telemetry Devices Market by Country 116
12.3.4.1 France Mobile Cardiac Telemetry Devices Market (2019-2025) 116
12.3.4.1.1 France Mobile Cardiac Telemetry Devices Market by Technology 117
12.3.4.1.2 France Mobile Cardiac Telemetry Devices Market by End-User 118
12.3.4.2 Germany Mobile Cardiac Telemetry Devices Market (2018-2025) 118
12.3.4.2.1 Germany Mobile Cardiac Telemetry Devices Market by Technology 121
12.3.4.2.2 Germany Mobile Cardiac Telemetry Devices Market by End-User 121
12.3.4.3 Sweden Mobile Cardiac Telemetry Devices Market (2018-2025) 122
12.3.4.3.1 Sweden Mobile Cardiac Telemetry Devices Market by Technology 124
12.3.4.3.2 Sweden Mobile Cardiac Telemetry Devices Market by End-User 125
12.3.4.4 Netherlands Mobile Cardiac Telemetry Devices Market (2018-2025) 125
12.3.4.4.1 Netherlands Mobile Cardiac Telemetry Devices Market by Technology 127
12.3.4.4.2 Case Study-Cost effectiveness of home telemonitoring (HTM) and nurse telephone support (NTS) 127
12.3.4.4.3 Netherlands Mobile Cardiac Telemetry Devices Market by End-User 128
12.3.4.5 Italy Mobile Cardiac Telemetry Devices Market (2018-2025) 128
12.3.4.5.1 Italy Mobile Cardiac Telemetry Devices Market by Technology 133
12.3.4.5.2 Italy Mobile Cardiac Telemetry Devices Market by End-User 133
12.3.4.6 United Kingdom Mobile Cardiac Telemetry Devices Market (2018-2025) 134
12.3.4.6.1 United Kingdom Mobile Cardiac Telemetry Devices Market by Technology 135
12.3.4.6.2 United Kingdom Mobile Cardiac Telemetry Devices Market by End-User 135
12.3.4.7 Rest of Europe Mobile Cardiac Telemetry Devices Market (2018-2025) 136
12.3.4.7.1 Rest of Europe Mobile Cardiac Telemetry Devices Market by Technology 136
12.3.4.7.2 Rest of Europe Mobile Cardiac Telemetry Devices Market by End-User 137
12.4 Asia Pacific Mobile Cardiac Telemetry Devices Market (2018-2025) 137
12.4.1 Asia Pacific Mobile Cardiac Telemetry Devices Market by Technology 138
12.4.2 Asia Pacific Mobile Cardiac Telemetry Devices Market by End-User 139
12.4.3 Asia Pacific Mobile Cardiac Telemetry Devices Market by Country 139
12.4.3.1 Japan Mobile Cardiac Telemetry Devices Market (2018-2025) 140
12.4.3.1.1 Japan Mobile Cardiac Telemetry Devices Market by Technology 141
12.4.3.1.2 Japan Mobile Cardiac Telemetry Devices Market by End-User 142
12.4.3.2 China Mobile Cardiac Telemetry Devices Market (2018-2025) 142
12.4.3.2.1 China Mobile Cardiac Telemetry Devices Market by Technology 144
12.4.3.2.2 China Mobile Cardiac Telemetry Devices Market by End-User 144
12.4.3.3 India Mobile Cardiac Telemetry Devices Market (2018-2025) 145
12.4.3.3.1 India Mobile Cardiac Telemetry Devices Market by Technology 146
12.4.3.3.2 India Mobile Cardiac Telemetry Devices Market by End-User 147
12.4.3.4 Rest of Asia Pacific Mobile Cardiac Telemetry Devices Market (2018-2025) 147
12.4.3.4.1 Rest of APAC Mobile Cardiac Telemetry Devices Market by Technology 148
12.4.3.4.2 Rest of APAC Mobile Cardiac Telemetry Devices Market by End-User 148
12.5 Rest of World Mobile Cardiac Telemetry Devices Market (2018-2025) 149
12.5.1 Rest of World Mobile Cardiac Telemetry Devices Market by Technology 150
12.5.2 Rest of World Mobile Cardiac Telemetry Devices Market by End-User 150
12.5.3 Rest of World Mobile Cardiac Telemetry Devices Market by Country 151
12.5.3.1 South Africa Mobile Cardiac Telemetry Devices Market (2018-2025) 151
12.5.3.1.1 South Africa Mobile Cardiac Telemetry Devices Market by Technology 153
12.5.3.1.2 South Africa Mobile Cardiac Telemetry Devices Market by End-User 153
12.5.3.2 Brazil Mobile Cardiac Telemetry Devices Market (2018-2025) 154
12.5.3.2.1 Brazil Mobile Cardiac Telemetry Devices Market by Technology 155
12.5.3.2.2 Brazil Mobile Cardiac Telemetry Devices Market by End-User 156
12.5.3.3 Other Countries Mobile Cardiac Telemetry Devices Market (2018-2025) 156
12.5.3.3.1 Other RoW Mobile Cardiac Telemetry Devices Market by Technology 156
12.5.3.3.2 Other RoW Mobile Cardiac Telemetry Devices Market by End User 157
13. COMPETITIVE SCENARIO 158
13.1 Porter’s Five forces analysis 158
13.1.1 Bargaining power of the Supplier 158
13.1.2 Bargaining power of Buyer 159
13.1.3 Industry Rivalry 159
13.1.4 Availability of Substitute 159
13.1.5 Threat of New Entrants 159
13.2 Market Share Analysis, by Company 2018 160
13.2.1 Some Major agreements of BioTelemetry 160
13.2.2 Market Share of Key Players in Mobile Cardiac Telemetry Devices, 2018 161
14. TOP COMPANY PROFILES 163
14.1 Asahi Kasei Corporation 163
14.1.1 Key Facts 163
14.1.2 Business Description 163
14.1.3 Key Product/Services Offerings 164
14.1.4 Growth Strategy 165
14.1.5 SWOT Analysis 167
14.1.6 Key Financials 168
14.1.6.1 Revenue Split 169
14.1.7 Recent Developments 169
14.1.7.1 Product Launches 169
14.1.7.2 Partnerships 170
14.1.7.3 Mergers and Acquisitions 170
14.2 BioTelemetry Inc. 171
14.2.1 Key Facts 171
14.2.2 Business Description 171
14.2.3 Key Product/Services Offerings 172
14.2.4 Growth Strategy 172
14.2.5 SWOT Analysis 173
14.2.6 Key Financials 174
14.2.6.1 Revenue Split 175
14.2.7 Recent Developments 175
14.2.7.1 Partnerships (Strategic Alliance) 175
14.2.7.2 Mergers and Acquisitions 175
14.3 Biotricity 177
14.3.1 Key Facts 177
14.3.2 Business Description 177
14.3.3 Key Product/Services Offerings 178
14.3.4 Growth Strategy 180
14.3.5 SWOT Analysis 181
14.3.6 Key Financials 181
14.3.7 Recent Developments 182
14.3.7.1 Biotricity Product Launch 182
14.3.7.2 Biotricity Business Expansion and Investment 183
14.4 Comarch 184
14.4.1 Key Facts 184
14.4.2 Business Description 184
14.4.3 Key Product/Services Offerings 185
14.4.4 Growth Strategy 186
14.4.5 SWOT Analysis 187
14.4.6 Key Financials 188
14.4.6.1 Revenue Split 189
14.4.7 Recent Developments 189
14.4.7.1 Partnership 189
14.4.7.2 Business Expansion & Investments 190
14.5 Hill-Rom Holdings Inc 191
14.5.1 Key Facts 191
14.5.2 Business Description 191
14.5.3 Key Product/Services Offerings 192
14.5.4 Growth Strategy 193
14.5.5 SWOT Analysis 195
14.5.6 Key Financials 196
14.5.6.1 Revenue Split 197
14.5.7 Recent Developments 197
14.5.7.1 Product Launches 197
14.5.7.2 Partnership 198
14.5.7.3 Expansions and Investments 198
14.5.7.4 Mergers and Acquisitions 198
14.5.7.5 Product Launches 199
14.6 Infobionic 200
14.6.1 Key Facts 200
14.6.2 Business Description 200
14.6.3 Key Product/Services Offerings 200
14.6.4 Growth Strategy 201
14.6.5 SWOT Analysis 202
14.6.6 Recent Developments 203
14.6.6.1 Product Launch 203
14.6.6.2 Business Expansion and Investment 203
14.7 Koninklijke Philips N.V. 204
14.7.1 Key Facts 204
14.7.2 Business Description 204
14.7.3 Key Product/Services Offerings 205
14.7.4 SWOT Analysis 207
14.7.5 Key Financials 208
14.7.5.1 Revenue Split, by Region and Segment 209
14.7.6 Recent Developments 209
14.7.6.1 Product Launches 209
14.7.6.2 Partnership 210
14.7.6.3 Merger and Acquisition 210
14.8 Medicalgorithmics 211
14.8.1 Key Facts 211
14.8.2 Business Description 211
14.8.3 Key Product/Services Offerings 212
14.8.4 SWOT Analysis 214
14.8.5 Key Financials 215
14.8.5.1 Revenue Split 216
14.8.6 Recent Developments 216
14.8.6.1 Product Launch 216
14.8.6.2 Partnerships 217
14.8.6.3 Business Expansions and Investments 217
14.8.6.4 Merger & Acquisitions 217
14.9 Medicomp 218
14.9.1 Key Facts 218
14.9.2 Business Description 218
14.9.3 Key Product/Services Offerings 218
14.9.4 SWOT Analysis 220
14.9.5 Recent Developments 220
14.9.5.1 Product Launches 220
14.10 Preventice Solutions 221
14.10.1.1 Key Facts 221
14.10.2 Business Description 221
14.10.3 Key Product/Services Offerings 222
14.10.4 SWOT Analysis 224
14.10.5 Recent Developments 225
14.10.5.1 Product Launches 225
TABLE 2 Patients’ Digital Health Adoption for Measuring Fitness and Health Improvement (2015) 34
TABLE 3 Number and distribution of persons aged 60 years or over by region, in 2017 and 2050 36
TABLE 4 Top 10 Destinations for Medical Tourism 38
TABLE 5 Summary of Security Threats and Risks in PHDs 43
TABLE 6 Strengths and Efficacies of Different Transitional Care Models and Interventions 46
TABLE 7 Characteristics of ambulatory cardiac monitoring devices 49
TABLE 8 Estimated diagnostic yield of different AECG recording modalities 51
TABLE 9 Advantages and Major Limitations of AECG Techniques 52
TABLE 10 2014 CPT codes for AECG monitoring, Medicare fee schedule, and approved indications 54
TABLE 11 Reimbursement models in Europe 56
TABLE 12 Physician notification criteria for ambulatory cardiovascular telemetry 58
TABLE 13 Reimbursement of cardiologic activities from the NHS 59
TABLE 14 Policy Coverage Criteria 60
TABLE 15 Ambulatory Cardiac Rhythm Monitoring Devices 60
TABLE 16 Applicable Codes 62
TABLE 17 Codes for implantable cardiac monitoring devices (requires precertification) 63
TABLE 18 Codes that do not meet payment determination criteria: 63
TABLE 19 Select Recommendations for Ambulatory ECG and External Monitoring or Telemetry 64
TABLE 20 Provider awareness of telemetry use 68
TABLE 21 Top Product Launches under Mobile Cardiac Telemetry Devices 71
TABLE 22 Top Partnerships under Mobile Cardiac Telemetry Devices 73
TABLE 23 Top Mergers & Acquisitions under Mobile Cardiac Telemetry Devices 74
TABLE 24 Top Business Expansion & Investment under Mobile Cardiac Telemetry Devices 76
TABLE 25 Indications for telemetry include, in consultation with the cardiology team, but not limited to 81
TABLE 26 Commercially Available Lead Based Mobile Telemetry Monitoring Systems 83
TABLE 27 A comprehensive overview of Existing Mobile Cardiac Monitoring devices 87
TABLE 28 Valuation of the B2C telemonitoring venture in the fifth year (in million US dollars) - Netherlands 127
TABLE 29 The Italian experience in TM programs 131
TABLE 30 mHealth benefits in 2017 - Brazil 155
TABLE 31 Number of people with the four heart conditions in Brazil, 2015 156
TABLE 32 Asahi Kasei Corporation Key Facts 164
TABLE 33 The product segmentation of Asahi Kasei Corporation 165
TABLE 34 Asahi Kasei Corporation Growth Strategy 166
TABLE 35 Asahi Kasei Corporation Product Launches 170
TABLE 36 Asahi Kasei Corporation Partnerships 171
TABLE 37 Asahi Kasei Corporation Mergers and Acquisitions 171
TABLE 38 BioTelemetry Inc. Key Facts 172
TABLE 39 The product segmentation of BioTelemetry Inc. 173
TABLE 40 BioTelemetry Inc. Growth Strategy 173
TABLE 41 BioTelemetry Inc. Partnerships (Strategic Alliance) 176
TABLE 42 BioTelemetry Inc. Merger and Acquisitions 176
TABLE 43 Biotricity Key Facts 178
TABLE 44 The product segmentation of Biotricity 179
TABLE 45 Biotricity Growth Strategy 181
TABLE 46 Biotricity Product Launch 183
TABLE 47 Biotricity Business Expansion and Investments 184
TABLE 48 Comarch Key Facts 185
TABLE 49 Product segmentation of Comarch 186
TABLE 50 Comarch Growth Strategy 187
TABLE 51 Comarch Partnership 190
TABLE 52 Comarch Business Expansion & Investments 191
TABLE 53 Hill-Rom Holdings Inc, Inc Key Facts 192
TABLE 54 The product segmentation of Hill-Rom Holdings Inc 193
TABLE 55 Hill-Rom Holdings Inc Growth Strategy 194
TABLE 56 Hill-Rom Holdings Inc Product Launches 198
TABLE 57 Hill-Rom Holdings Inc Partnership 199
TABLE 58 Hill-Rom Holdings Inc Expansions and Investments 199
TABLE 59 Hill-Rom Holdings Inc Mergers and Acquisitions 199
TABLE 60 Hill-Rom Holdings Inc Product Launches 200
TABLE 61 Infobionic Key Facts 201
TABLE 62 The product segmentation of InfoBionic 201
TABLE 63 Infobionic Growth Strategy 202
TABLE 64 Infobionic Product Launch 204
TABLE 65 Infobionic Business Expansion and Investment 204
TABLE 66 Koninklijke Philips N.V. Key Facts 205
TABLE 67 The product segmentation of Koninklijke Philips N.V. 206
TABLE 68 Koninklijke Philips N.V. Growth Strategy 207
TABLE 69 Koninklijke Philips N.V. Product Launches 210
TABLE 70 Koninklijke Philips N.V. Partnership 211
TABLE 71 Koninklijke Philips N.V. Merger and Acquisition 211
TABLE 72 Medicalgorithmics Key Facts 212
TABLE 73 The product segmentation of Medicalgorithmics 213
TABLE 74 Medicalgorithmics Growth Strategy 214
TABLE 75 Medicalgorithmics Product Launch 217
TABLE 76 Medicalgorithmics Partnerships 218
TABLE 77 Medicalgorithmics Business Expansions and Investments 218
TABLE 78 Medicalgorithmics Merger & Acquisitions 218
TABLE 79 Medicomp Key Facts 219
TABLE 80 The product segmentation of Medicomp 219
TABLE 81 Medicomp Growth Strategy 220
TABLE 82 Medicomp Corp Product Launches 221
TABLE 83 Preventice Solutions Key Facts 222
TABLE 84 The product segmentation of Preventice Solutions 223
TABLE 85 Preventice Solutions Growth Strategy 224
TABLE 86 Preventice Solutions Product Launches 226
Similar Reports
The global digital pathology market was valued at $3,323 million in 2016, and is expected to reach $8,668 million by 2023, registering a CAGR of 14.8% during the forecast period. Digital pathology is defined as an image-based information setting enabled b...
- Publish Date: February 26, 2018
- $5370
The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...
- Publish Date: May 29, 2018
- $5370
The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...
- Publish Date: May 1, 2016
- $5370
